NBT Bank N A NY Has $5.65 Million Holdings in Danaher Co. (DHR)

Share on StockTwits

NBT Bank N A NY lowered its stake in shares of Danaher Co. (NYSE:DHR) by 0.9% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 42,765 shares of the conglomerate’s stock after selling 398 shares during the period. Danaher makes up approximately 1.0% of NBT Bank N A NY’s portfolio, making the stock its 28th biggest holding. NBT Bank N A NY’s holdings in Danaher were worth $5,646,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc boosted its stake in shares of Danaher by 1.4% in the 3rd quarter. Vanguard Group Inc now owns 44,738,984 shares of the conglomerate’s stock worth $4,861,338,000 after buying an additional 605,018 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Danaher by 0.5% in the 4th quarter. BlackRock Inc. now owns 43,634,997 shares of the conglomerate’s stock worth $4,499,639,000 after buying an additional 207,468 shares during the last quarter. FMR LLC boosted its stake in shares of Danaher by 1.4% in the 4th quarter. FMR LLC now owns 22,035,846 shares of the conglomerate’s stock worth $2,272,336,000 after buying an additional 296,095 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Danaher by 8.4% in the 4th quarter. Geode Capital Management LLC now owns 7,527,142 shares of the conglomerate’s stock worth $774,743,000 after buying an additional 583,194 shares during the last quarter. Finally, Norges Bank purchased a new position in shares of Danaher in the 4th quarter worth approximately $747,082,000. Institutional investors and hedge funds own 76.98% of the company’s stock.

NYSE:DHR opened at $130.32 on Tuesday. The company has a current ratio of 2.18, a quick ratio of 1.74 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $93.86 billion, a P/E ratio of 28.83, a P/E/G ratio of 2.53 and a beta of 1.02. Danaher Co. has a 12 month low of $94.59 and a 12 month high of $134.67.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.06. The company had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.80 billion. Danaher had a net margin of 12.04% and a return on equity of 11.61%. Danaher’s revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.99 EPS. As a group, sell-side analysts expect that Danaher Co. will post 4.77 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.17 dividend. The ex-dividend date is Thursday, June 27th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.52%. Danaher’s dividend payout ratio (DPR) is presently 15.04%.

In related news, SVP Angela S. Lalor sold 3,091 shares of Danaher stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $132.23, for a total value of $408,722.93. Following the sale, the senior vice president now owns 38,515 shares of the company’s stock, valued at approximately $5,092,838.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Walter G. Lohr sold 10,578 shares of Danaher stock in a transaction that occurred on Wednesday, February 27th. The stock was sold at an average price of $126.85, for a total transaction of $1,341,819.30. Following the completion of the sale, the director now directly owns 20,691 shares in the company, valued at approximately $2,624,653.35. The disclosure for this sale can be found here. Insiders sold a total of 455,032 shares of company stock worth $58,998,917 in the last ninety days. 11.40% of the stock is currently owned by insiders.

A number of brokerages have recently weighed in on DHR. Zacks Investment Research upgraded Danaher from a “sell” rating to a “hold” rating in a research note on Monday, May 6th. Needham & Company LLC restated a “buy” rating and issued a $141.00 target price (up previously from $138.00) on shares of Danaher in a research note on Wednesday, April 17th. JPMorgan Chase & Co. restated an “overweight” rating and issued a $140.00 target price on shares of Danaher in a research note on Monday, March 4th. Janney Montgomery Scott boosted their target price on Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a research note on Wednesday, April 17th. Finally, Jefferies Financial Group boosted their target price on Danaher to $140.00 and gave the stock a “buy” rating in a research note on Tuesday, February 26th. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Danaher presently has a consensus rating of “Buy” and an average price target of $131.75.

ILLEGAL ACTIVITY WARNING: This piece was reported by Highlight Press and is owned by of Highlight Press. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://highlightpress.com/2019/05/21/nbt-bank-n-a-ny-has-5-65-million-holdings-in-danaher-co-dhr.html.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: What is a bull market?

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.